跳至主要内容
临床试验/IRCT2015083123823N1
IRCT2015083123823N1已完成2 期

Clinical evaluation of an Iranian traditional product (derived from plantago ovata) in the treatment of radiotherapy induced diarrhea Grade 1 to Grade 3

Shiraz University Of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with Grade 1 to Grade 3diarrhea, as described in Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 and experienced during the 24-h period after a fraction of radiotherapy ;All patients had a histologically confirmed cancer ;age>18 years; absence of fever with white blood cell count of over 3,000/mm3.
  • exclusion criteria: Patients with Grade 4 diarrhea; diarrhea or stool incontinence before the beginning of irradiation; renal failure; past history of gastrointestinal
  • disorder known to cause diarrhea ;presence of an active intraluminal gastrointestinal tumor

排除标准

  • 未提供

研究者

相似试验